NO960684L - Monoklonalt antistoff som induserer apoptose - Google Patents
Monoklonalt antistoff som induserer apoptoseInfo
- Publication number
- NO960684L NO960684L NO960684A NO960684A NO960684L NO 960684 L NO960684 L NO 960684L NO 960684 A NO960684 A NO 960684A NO 960684 A NO960684 A NO 960684A NO 960684 L NO960684 L NO 960684L
- Authority
- NO
- Norway
- Prior art keywords
- antibody
- monoclonal antibody
- induces apoptosis
- myelocytic
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05242110 | 1993-09-03 | ||
PCT/JP1994/001453 WO1995006748A1 (fr) | 1993-09-03 | 1994-09-02 | Anticorps monoclonal permettant d'induire une apoptose |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960684L true NO960684L (no) | 1996-02-21 |
NO960684D0 NO960684D0 (no) | 1996-02-21 |
Family
ID=17084452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960684A NO960684D0 (no) | 1993-09-03 | 1996-02-21 | Monoklonalt antistoff som induserer apoptose |
Country Status (19)
Country | Link |
---|---|
US (4) | US5840344A (no) |
EP (1) | EP0721015B1 (no) |
KR (1) | KR100241863B1 (no) |
CN (1) | CN1046314C (no) |
AT (1) | ATE280835T1 (no) |
AU (1) | AU692466B2 (no) |
CA (1) | CA2169950A1 (no) |
CZ (1) | CZ294359B6 (no) |
DE (1) | DE69434097T2 (no) |
FI (1) | FI960567A (no) |
HU (1) | HU222989B1 (no) |
NO (1) | NO960684D0 (no) |
PL (1) | PL181783B1 (no) |
RU (1) | RU2202615C2 (no) |
SK (1) | SK281964B6 (no) |
TW (1) | TW426687B (no) |
UA (1) | UA50708C2 (no) |
WO (1) | WO1995006748A1 (no) |
ZA (1) | ZA946767B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840344A (en) * | 1993-09-03 | 1998-11-24 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibodies having property of causing apoptosis |
AU2232597A (en) * | 1996-03-06 | 1997-09-22 | Chugai Seiyaku Kabushiki Kaisha | Method of screening apoptosis inducing substances |
DE69733204T3 (de) | 1996-07-15 | 2012-03-08 | Chugai Seiyaku K.K. | Neuartige vegf-ähnliche faktoren |
US7531643B2 (en) | 1997-09-11 | 2009-05-12 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibody inducing apoptosis |
CN1198845C (zh) * | 1997-09-11 | 2005-04-27 | 中外制药株式会社 | 诱导编程性细胞死亡的单克隆抗体 |
US7696325B2 (en) * | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
WO2000053634A1 (fr) * | 1999-03-10 | 2000-09-14 | Chugai Seiyaku Kabushiki Kaisha | Fv monocatenaire induisant l'apoptose |
US20040058393A1 (en) * | 2000-04-17 | 2004-03-25 | Naoshi Fukishima | Agonist antibodies |
CN1308448C (zh) | 2000-10-20 | 2007-04-04 | 中外制药株式会社 | 低分子化的tpo激动剂抗体 |
EP2351838A1 (en) * | 2000-10-20 | 2011-08-03 | Chugai Seiyaku Kabushiki Kaisha | Crosslinking agonistic antibodies |
US7195771B1 (en) | 2000-11-21 | 2007-03-27 | Kimberly-Clark Worldwide, Inc. | Water-soluble lotions for paper products |
WO2003044482A2 (en) * | 2001-11-16 | 2003-05-30 | The University Of Tennessee Research Corporation | Recombinant antibody fusion proteins and methods for detection of apoptotic cells |
EP1561759B9 (en) | 2002-10-11 | 2009-08-26 | Chugai Seiyaku Kabushiki Kaisha | Cell death-inducing agent |
JP2004279086A (ja) * | 2003-03-13 | 2004-10-07 | Konica Minolta Holdings Inc | 放射線画像変換パネル及び放射線画像変換パネルの製造方法 |
EP1609803A4 (en) * | 2003-03-31 | 2006-05-24 | Chugai Pharmaceutical Co Ltd | MODIFIED ANTIBODY AGAINST CD22 AND ITS USE |
TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
TW200530266A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Method of reinforcing antibody activity |
EP1712565A4 (en) * | 2003-12-12 | 2009-03-11 | Chugai Pharmaceutical Co Ltd | AGENTS INDUCING CELL DEATH |
WO2005056602A1 (ja) * | 2003-12-12 | 2005-06-23 | Chugai Seiyaku Kabushiki Kaisha | アゴニスト活性を有する改変抗体のスクリーニング方法 |
US9493569B2 (en) * | 2005-03-31 | 2016-11-15 | Chugai Seiyaku Kabushiki Kaisha | Structural isomers of sc(Fv)2 |
WO2006123724A1 (ja) * | 2005-05-18 | 2006-11-23 | The University Of Tokushima | 抗hla抗体を利用した新規医薬品 |
KR101360671B1 (ko) | 2005-06-10 | 2014-02-07 | 추가이 세이야쿠 가부시키가이샤 | sc(Fv)2를 함유하는 의약조성물 |
EP1908482B1 (en) | 2005-06-10 | 2017-09-06 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
WO2007100892A2 (en) * | 2006-02-28 | 2007-09-07 | The Board Of Trustees Of The Leland Stanford Junior University | Trojan horse immunotherapy |
KR20090038896A (ko) * | 2006-07-13 | 2009-04-21 | 추가이 세이야쿠 가부시키가이샤 | 세포사 유도제 |
CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
CN109072199B (zh) | 2014-12-05 | 2022-10-28 | 纪念斯隆-凯特琳癌症中心 | 靶向Fc受体样5的嵌合抗原受体及其用途 |
CN109071654B (zh) | 2015-12-04 | 2022-09-23 | 纪念斯隆-凯特琳癌症中心 | 靶向Fc受体样5的抗体及使用方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840344A (en) * | 1993-09-03 | 1998-11-24 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibodies having property of causing apoptosis |
AU2232597A (en) * | 1996-03-06 | 1997-09-22 | Chugai Seiyaku Kabushiki Kaisha | Method of screening apoptosis inducing substances |
CN1198845C (zh) * | 1997-09-11 | 2005-04-27 | 中外制药株式会社 | 诱导编程性细胞死亡的单克隆抗体 |
WO2000053634A1 (fr) * | 1999-03-10 | 2000-09-14 | Chugai Seiyaku Kabushiki Kaisha | Fv monocatenaire induisant l'apoptose |
-
1994
- 1994-09-02 US US08/605,059 patent/US5840344A/en not_active Expired - Lifetime
- 1994-09-02 CZ CZ1996617A patent/CZ294359B6/cs not_active IP Right Cessation
- 1994-09-02 AU AU75466/94A patent/AU692466B2/en not_active Ceased
- 1994-09-02 EP EP94925618A patent/EP0721015B1/en not_active Expired - Lifetime
- 1994-09-02 UA UA96030813A patent/UA50708C2/uk unknown
- 1994-09-02 HU HU9600206A patent/HU222989B1/hu not_active IP Right Cessation
- 1994-09-02 RU RU96107203/13A patent/RU2202615C2/ru not_active IP Right Cessation
- 1994-09-02 CN CN94193260A patent/CN1046314C/zh not_active Expired - Fee Related
- 1994-09-02 AT AT94925618T patent/ATE280835T1/de not_active IP Right Cessation
- 1994-09-02 ZA ZA946767A patent/ZA946767B/xx unknown
- 1994-09-02 SK SK255-96A patent/SK281964B6/sk unknown
- 1994-09-02 DE DE69434097T patent/DE69434097T2/de not_active Expired - Fee Related
- 1994-09-02 KR KR1019960700821A patent/KR100241863B1/ko not_active IP Right Cessation
- 1994-09-02 PL PL94313260A patent/PL181783B1/pl not_active IP Right Cessation
- 1994-09-02 WO PCT/JP1994/001453 patent/WO1995006748A1/ja active IP Right Grant
- 1994-09-02 CA CA002169950A patent/CA2169950A1/en not_active Abandoned
- 1994-11-19 TW TW083110887A patent/TW426687B/zh not_active IP Right Cessation
-
1996
- 1996-02-07 FI FI960567A patent/FI960567A/fi not_active Application Discontinuation
- 1996-02-21 NO NO960684A patent/NO960684D0/no not_active Application Discontinuation
-
1998
- 1998-09-17 US US09/154,498 patent/US6267959B1/en not_active Expired - Lifetime
-
2000
- 2000-12-15 US US09/736,146 patent/US6759043B2/en not_active Expired - Fee Related
-
2003
- 2003-03-03 US US10/376,628 patent/US20030147894A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL313260A1 (en) | 1996-06-24 |
CN1046314C (zh) | 1999-11-10 |
EP0721015B1 (en) | 2004-10-27 |
HU222989B1 (hu) | 2004-01-28 |
ZA946767B (en) | 1995-04-03 |
CN1130405A (zh) | 1996-09-04 |
WO1995006748A1 (fr) | 1995-03-09 |
EP0721015A1 (en) | 1996-07-10 |
US20030147894A1 (en) | 2003-08-07 |
DE69434097T2 (de) | 2006-02-02 |
CZ294359B6 (cs) | 2004-12-15 |
FI960567A0 (fi) | 1996-02-07 |
HU9600206D0 (en) | 1996-03-28 |
DE69434097D1 (de) | 2004-12-02 |
FI960567A (fi) | 1996-02-07 |
SK25596A3 (en) | 1996-10-02 |
KR100241863B1 (ko) | 2000-03-02 |
ATE280835T1 (de) | 2004-11-15 |
UA50708C2 (uk) | 2002-11-15 |
US5840344A (en) | 1998-11-24 |
AU7546694A (en) | 1995-03-22 |
HUT74594A (en) | 1997-01-28 |
CA2169950A1 (en) | 1995-03-09 |
CZ61796A3 (en) | 1996-06-12 |
AU692466B2 (en) | 1998-06-11 |
US6267959B1 (en) | 2001-07-31 |
US6759043B2 (en) | 2004-07-06 |
PL181783B1 (pl) | 2001-09-28 |
NO960684D0 (no) | 1996-02-21 |
SK281964B6 (sk) | 2001-09-11 |
RU2202615C2 (ru) | 2003-04-20 |
EP0721015A4 (en) | 1999-03-31 |
US20010001712A1 (en) | 2001-05-24 |
TW426687B (en) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO960684D0 (no) | Monoklonalt antistoff som induserer apoptose | |
NO2017040I2 (no) | Natalizumab, anti alfa-4 integrin humanisert monoklonalt antistoff - forlenget SPC | |
DE69321218D1 (de) | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 | |
NO20001238D0 (no) | Monoklonalt antistoff som induserer apoptose | |
DE69532889D1 (de) | Interleukin-5-spezifische rekombinante antikörper | |
NO944247D0 (no) | Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor | |
ATE160575T1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
ITRM920457A0 (it) | Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteinaumana. | |
DK0840620T3 (da) | IL-8-antagonister til behandling af astma | |
EA200400930A1 (ru) | Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний | |
TR199501542A2 (tr) | Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari. | |
DE3580482D1 (de) | Monoklonale antikoerper und immunisierung damit. | |
ATE318844T1 (de) | Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii | |
NO894555L (no) | Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet. | |
ITRM920223A0 (it) | Anticorpi monoclonali anti-idiopici diretti contro anticorpi anti-tnf. | |
ATE136469T1 (de) | Neue verwendung eines monoklonalen antikörpers | |
ATE110786T1 (de) | Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa. | |
ES2051870T3 (es) | Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t. | |
ATE58173T1 (de) | Monoklonale antikoerper und immunisierung damit. | |
NO960683L (no) | Monoklonalt antistoff som gjenkjenner interstitialcelle-overflateantigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |